NDC 53145-697 – Mucosan Severe Multi-Symptom
Phenylephrine Hydrochloride 10 mg/20mL; Dextromethorphan Hydrobromide 20 mg/20mL; Guaifenesin 400 mg/20mL · Liquid · Oral
Product NDC53145-697
Product details
- Brand name
- Mucosan Severe Multi-Symptom
- Generic name
- DEXTROMETHORPHAN HBr, GUAIFENESIN, PHENYLEPHRINE HCL
- Labeler
- Menper Distributors, Inc.
- Dosage form
- Liquid
- Route
- Oral
- Marketing category
- OTC MONOGRAPH DRUG · M012
- Marketed since
- November 1, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Expectorant; Sigma-1 Agonist; Uncompetitive N-methyl-D-aspartate Receptor Antagonist; alpha-1 Adrenergic Agonist
Active ingredients
- Phenylephrine Hydrochloride 10 mg/20mL
- Dextromethorphan Hydrobromide 20 mg/20mL
- Guaifenesin 400 mg/20mL
Uses, dosage, side effects and warnings for Mucosan Severe Multi-Symptom →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 53145-697-06 | 1 BOTTLE, PLASTIC in 1 CARTON (53145-697-06) / 177 mL in 1 BOTTLE, PLASTIC | Nov 1, 2024 |